Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Headquarters
11801 Research Drive
Suite D
Alachua, FL, 32615
USA

People

Chairman of the Board of Directors
President and CEO
Board Director
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Chief Medical Officer and VP of Regulatory Affairs

Funding

TOTAL $77.3M
FUNDING TOTAL $77.3M
Series B, 11/2003
InterWest Partners
Skyline Ventures
Intersouth Partners
MedImmune Ventures
$27M
Series C, 6/2009
Intersouth Partners
InterWest Partners
MedImmune Ventures
$11.8M
Grant, 9/2010
$1M
Series B, 11/2012
Alta Partners
Osage University Partners
InterWest Partners
Intersouth Partners
MedImmune Ventures
SR One
$37.5M
DEBT TOTAL $750k
Debt, 5/2012
$750k

Tags

Applied Genetics Technologies Corporation

Applied Genetic Technologies Corporation (AGTC) was founded by five scientific leaders in the use of viral vectors for Gene Therapy and began operations in 2001. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus (AAV) to gene therapy. Since that time the Company has signed licenses to over 40 US and foreign patents, raised over $45M in venture financing from blue chip investors and has five products in active development, one of which is partnered to Genzyme Corporation.

AGTC’s most recent round of financing was completed in April 2009 and was led by Interwest Partners of Menlo Park, CA. Other investors included Intersouth Partners of RTP, NC and MedImmune Ventures of Gaithersburg, MD.

Recent Milestones

Videos

Screenshots

Applied Genetics Technologies Corporation screenshot
Above: Applied Genetics Technologies Corporation Screenshot -- #1
Uploaded: 6/17/09

Sources

  1. Company Overview (agtc.com) [edit]
  2. Applied Genetic Technologies Corp.: Series C $11.8M (onbiovc.com) [edit]
  3. Applied Genetic Technologies Corporation Receives Grant from FDA for Clinical Study of Genetic Retinal Disease (biospace.com) [edit]
  4. SEC (sec.gov) [edit]
  5. Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding (biospace.com) [edit]
Edit This Page
Last Edited 11/22/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy